GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
2022-05-11 $0.710 $0.710 $0.582 $0.615 635 750
2022-05-10 $0.760 $0.80 $0.700 $0.716 563 748
2022-05-09 $0.82 $0.82 $0.750 $0.759 572 710
2022-05-06 $0.86 $0.88 $0.80 $0.82 632 777
2022-05-05 $0.93 $0.93 $0.86 $0.87 318 667
2022-05-04 $0.96 $0.98 $0.88 $0.91 657 328
2022-05-03 $0.92 $0.97 $0.92 $0.95 298 651
2022-05-02 $0.93 $0.94 $0.89 $0.93 314 710
2022-04-29 $0.94 $0.98 $0.90 $0.90 356 193
2022-04-28 $0.92 $0.94 $0.90 $0.94 310 476
2022-04-27 $0.96 $0.96 $0.89 $0.92 368 429
2022-04-26 $0.97 $1.00 $0.91 $0.92 668 969
2022-04-25 $1.00 $1.02 $0.97 $0.99 599 918
2022-04-22 $1.03 $1.04 $1.00 $1.02 136 269
2022-04-21 $1.07 $1.12 $1.01 $1.03 776 300
2022-04-20 $1.09 $1.10 $1.05 $1.07 365 600
2022-04-19 $1.06 $1.10 $1.05 $1.08 339 400
2022-04-18 $1.11 $1.12 $1.03 $1.05 486 500
2022-04-14 $1.05 $1.13 $1.02 $1.11 775 645
2022-04-13 $1.00 $1.05 $1.00 $1.04 582 385
2022-04-12 $1.00 $1.05 $0.98 $0.98 428 898
2022-04-11 $1.05 $1.06 $0.96 $1.01 897 944
2022-04-08 $1.08 $1.09 $1.04 $1.05 344 608
2022-04-07 $1.09 $1.11 $1.04 $1.08 572 900
2022-04-06 $1.09 $1.09 $1.06 $1.09 514 700
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT